Year: 2010
Resolution Number: 64
Action Taken: Referred to the Board
Status:
Author(s): Clyde R. Flory, MD
Sponsor: Gail A. Cookingham, MD
On behalf of: Michigan Allergy and Asthma Society
Committee: C (Internal Affairs and Public Service) [Pre-2014]
Resolved Section(s):
RESOLVED: That MSMS legal counsel review the current legal restraints of distributing unopened and outdated medications to patients; and be it further,RESOLVED: That MSMS alert our members, component medical societies, and appropriate local medical facilities that the Department of Defense/U.S. Food and Drug Administration Shelf Life Extension Program has studied 122 drugs beyond their expiration dates and found that 88 percent of the lots tested remained stable for an average of 66 months beyond their expirations dates as published in the December 14/28 2009 The Medical Letter, and where needed and feasible (perhaps by working with MSMS Alliance members), component medical societies be asked to consider developing an ongoing method of redistribution of these medicines to deserving charities, clinics, or other suitable organizations; and be it further,RESOLVED: That the Michigan Delegation to the AMA ask the AMA to seek approval from the U.S. Food and Drug Administration to use the 122 drugs studied in the Department of Defense/FDA Shelf Life Extension Program as published in the December 14/28 2009 The Medical Letter by deserving charities, clinics, or other suitable organizations.RATIONALE: The Committee extensively discussed this resolution and agreed with the spirit of the resolution. However, the Committee believed that due to the complex liability and legal issues involved in using expired drugs, further study is needed.
RESOLVED: That MSMS legal counsel review the current legal restraints of distributing unopened and outdated medications to patients; and be it further,RESOLVED: That MSMS alert our members, component medical societies, and appropriate local medical facilities that the Department of Defense/U.S. Food and Drug Administration Shelf Life Extension Program has studied 122 drugs beyond their expiration dates and found that 88 percent of the lots tested remained stable for an average of 66 months beyond their expirations dates as published in the December 14/28 2009 The Medical Letter, and where needed and feasible (perhaps by working with MSMS Alliance members), component medical societies be asked to consider developing an ongoing method of redistribution of these medicines to deserving charities, clinics, or other suitable organizations; and be it further,RESOLVED: That the Michigan Delegation to the AMA ask the AMA to seek approval from the U.S. Food and Drug Administration to use the 122 drugs studied in the Department of Defense/FDA Shelf Life Extension Program as published in the December 14/28 2009 The Medical Letter by deserving charities, clinics, or other suitable organizations.RATIONALE: The Committee extensively discussed this resolution and agreed with the spirit of the resolution. However, the Committee believed that due to the complex liability and legal issues involved in using expired drugs, further study is needed.
Fiscal Note: NULL
Resolution: View PDF for Use of Expired Drugs by Charitable Clinics